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Abstract: Nano-hydroxyapatite/polyamide 66 (nHA/PA66) composite with good bioactivity 
and osteoconductivity was employed to develop a novel porous membrane with asymmetric 
structure for guided bone regeneration (GBR). In order to test material cytotoxicity and to inves-
tigate surface-dependent responses of bone-forming cells, the morphology, proliferation, and cell 
cycle of bone marrow stromal cells (BMSCs) of rats cultured on the prepared membrane were 
determined. The polygonal and fusiform shape of BMSCs was observed by scanning electronic 
microscopy (SEM). The proliferation of BMSCs cultured on nHA/PA66 membrane tested by the 
MTT method (MTT: [3-{4,5-dimethylthiazol-2yl}-2,5-diphenyl-2H-tetrazoliumbromide]) was 
higher than that of negative control groups for 1 and 4 days’ incubation and had no significant 
difference for 7 and 11 days’ culture. The results of cell cycle also suggested that the membrane 
has no negative influence on cell division. The nHA/PA66 membranes were then implanted into 
subcutaneous sites of nine Sprague Dawley rats. The wounds and implant sites were free from 
suppuration and necrosis in all periods. All nHA/PA66 membranes were surrounded by a fibrous 
capsule with decreasing thickness 1 to 8 weeks postoperatively. In conclusion, the results of 
the in vitro and in vivo studies reveal that nHA/PA66 membrane has excellent biocompatibility 
and indicate its use in guided tissue regeneration (GTR) or GBR.
Keywords: hydroxyapatite/polyamide, barrier membrane, biocompatibility, guided bone 
regeneration
Introduction
Guided tissue regeneration (GTR) using barrier membranes has been proven as an 
  effective modality in periodontal therapy.1 The barrier membrane technique was 
employed to guide bone regeneration in the bone defect site and given the name of 
“guided bone regeneration (GBR)” by some researchers.2 Criteria for ideal   barrier 
  membranes include biocompatibility, cell occlusiveness, space making, tissue 
  integration and clinical manageability. In the past twenty years, nonabsorbable3–6 and 
absorbable membranes7–11 had been studied and applied to GTR or GBR techniques. 
However, both the absorbable and nonabsorbable barrier membranes have their 
  shortcomings and the available products are limited.12–14
The main disadvantage for absorbable membranes is unexpected absorption ahead 
of sufficient bone forming,6 while the main disadvantage for nonabsorbable membranes 
is the need for a second surgery.15
The nano-hydroxyapatite/polyamide 66 (nHA/PA66) composite developed by our 
research group is a biomimetic and bioactive material for bone repair engineering.16 
The nHA/PA66 composite dramatically resembles natural bone in its composition, 
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structure, and mechanical properties, which is   responsible 
for its good biocompatibility, osteoconductivity, and 
bioactivity.17–19 Our previous study revealed that the incor-
poration of nano-hydroxyapatite (nHA) in a polyamide 66 
(PA66) matrix could improve properties of the membrane 
substantially. The elongation at break and the tensile strength 
suggest that the composite membrane (with 40 wt% of nHA) 
has good strength and toughness.20
In order to overcome the drawbacks of the currently-used 
barrier membranes and to provide an optimal alternative, 
our hypothesis is to develop a novel nHA/PA66 membrane 
which is nonabsorbable in nature and does not require 
retrieval.
This study assesses the in vitro cytotoxicity and in vivo 
biocompatibility of the novel membrane. The morphol-
ogy, proliferation, and cell cycle of bone marrow stromal 
cells (BMSCs) of rats cultured on the prepared membrane 
were determined to test the material’s cytotoxicity. In vivo 
biocompatibility was investigated in healthy Sprague-
Dawley rats.
Materials and methods
Materials
PA66 with a viscosity-average molecular weight (Mv) of 
18 kDa was obtained from BASF, (Ludwigshafen, Germany). 
The slurry of nano-hydroxyapatite used for the composite 
was prepared by our laboratory using the methods of wet 
synthesis and hydrothermal treatment.21,22
Fabrication of the nhA/PA66 membrane
The nHA/PA66 (4:6 in wt%) composite slurry was pre-
pared according to previous work.19 PA66 was completely 
dissolved in ethanol solution at 70°C. The nHA slurry was 
gradually added to the PA66/ethanol solution with vigor-
ous stirring for 2 h. The composite slurry was left standing 
for at least 4 h at room temperature to remove the bubbles. 
The slurry was poured onto a glass plate to form an even 
liquid film, which was then evaporated at room temperature 
for 24 h to form a membrane, and washed repeatedly with 
deionized water.
Membrane characterization
The microstructure of the nHA/PA66 membrane was 
observed under scanning electron microscope (SEM). The 
membranes were carefully sectioned with a razor blade and 
mounted onto copper stubs. Prior to examination, each   sample 
was coated with gold. A Hitachi S-450 SEM   microscope at 
20 kV was used to perform image analysis.
cell culture
BMSCs were obtained from the tibiae and femora of young 
Sprague-Dawley rats and cultured in α-MEM culture medium 
supplemented with 20% fetal FBS, 100 U/mL penicillin, 
100 mg/mL streptomycin, 0.219 mg/mL L-glutamine, 
100 mM HEPES buffer (Gibco, USA) in a humidified incu-
bator with 5% CO2 at 37°C. The culture media was changed 
every other day. The fourth passage BMSCs were used in 
the experiments.
cell seeding
The nHA/PA66 membrane was prepared in a square form 
(2 cm × 3 cm), sterilized by autoclaving, placed into 6-well 
culture plate, and seeded at a density of 3 × 106 cells/well in 
2 mL supplemented medium. The cell/membrane constructs 
were cultured in a humidified incubator at 37°C with 5% CO2 
for 7 days. The medium was changed every other day. Cells 
cultured without membranes were assigned as control.
cellular morphology
An inverted phase contrast microscope and a scanning 
electron microscope were used to determine cellular 
morphology.
BMSCs cultured on nHA/PA66 membrane were rinsed 
with phosphate buffered saline (PBS), fixed with 1% para-
formaldehyde, subjected to graded alcohol dehydrations, 
rinsed with PBS, sputter-coated with gold, and examined 
with a scanning electron microscope (JSM-5900LV , Hitachi). 
The growth of cells on the scaffolds was observed by SEM 
at 24 h and 96 h.
Analysis of proliferation of the BMscs
The proliferation of BMSCs cells cultured on the nHA/PA66 
membrane was determined by the MTT assay using an HTS 
7000 plus Bio Assay Reader (Perkin Elmer, USA). The 
medium was removed and 2 mL of MTT solution (5 mg/mL) 
was added to each well. Following incubation at 37°C for 
4 h in a fully-humidified atmosphere at 5% CO2 in air, MTT 
was taken up by active cells and reduced in the mitochondria 
to insoluble purple formazan granules. Subsequently, the 
medium was discarded and the precipitated formazan was 
dissolved in dimethyl sulfoxide (DMSO) (150 mL/well). 
The optical density of the solution was evaluated using a 
microplate spectrophotometer at a wavelength of 490 nm.
Analysis of cell cycle
At 1, 4, 7 days, cultures were trypsinized and centrifuged at 
1000 rpm for 8 min, then resuspended in 1 mL of 70%   ethanol. International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Cell cycle was determined using a flow cytometer (EPLCS® 
ELITE, Coulter, USA).
In vivo biocompatibility – subcutaneous 
implant test
Nine Sprague-Dawley rats were anesthetized by an introabdom-
inal injection of pentobarbital (Nembutal 3.5 mg/100 g BW) to 
undergo bilaterally dorsal subcutaneous implantation. Four 
subcutaneous pouches were created in the back of one rat, 
where membranes were implanted. After blunt dissection 
through the subcutaneous tissues, each rat received four 
pieces of membrane in the back. Skin incision was closed 
by simple interrupted sutures of monofilament nylon 4-0. 
The rats were randomly assigned into three groups with 
three in each group representing three different time points. 
The composites and surrounding   tissue were obtained and 
processed for histological analysis at 1, 4, and 8 weeks 
after implantation. All samples were fixed in 10% buffered 
formalin, decalcified (K-CX   solution, Falma Co., Tokyo, 
Japan), dehydrated, embedded in paraffin, and stained with 
hematoxylin and eosin. These samples were observed by 
optical microscope (Olympus, IX 70, Japan).
statistical analysis
Statistical analysis was performed with SPSS 11.5. For all 
experiments, the results are expressed as mean ± standard 
deviation, ‘n’ value was 5, and independent experiments were 
performed three times. Analysis of variance (ANOVA) was 
performed, followed by Student-Newman-Keuls multiple 
comparison test. When a difference between groups was 
identified by ANOVA, a comparison of group means was 
performed using a Student’s t-test. The value of P , 0.05 
was considered statistically significant.
Results and discussion
The microstructure of the membrane
Figure 1 shows that the membrane has an asymmetric porous 
structure, in which pores less than 10 µm are distributed 
on one side {microporous layer (Figure 1A)}, while pores 
ranging from 30 µm to 200 µm are located on the other 
side {macroporous layer (Figure 1B)}. The microporous 
layer of the membrane can prevent the fibrous connective 
tissue from migrating into the bony defect, while being 
able to permeate sufficient nutrients for the regenerated 
tissue. Meanwhile the spongy structure of the membrane 
can promote ingrowth of progenitor bone cells, leading to 
direct bonding between the original and regenerated tissue.23 
This particular layout features in the commercially avail-
able collagen bilayer membranes Bio-Gide®. Its dense and 
smooth outer surface is covered by a particularly dense film, 
aiming at preventing the invasion of undesirable gingival 
epithelium and connective tissue cells into the membrane-
protected area. The inner rough side of Bio-Gide® promotes 
the ingrowth of periodontal ligament (PDL) cells, bone cells, 
and cementoblasts.24
The growth of cells on the surface  
of porous nhA/PA66
The morphology of BMSCs anchored on nHA/PA66 as 
observed by SEM is shown in Figure 2. The polygonal and 
fusiform BMSCs were well distributed over the membranes 
at various incubation periods. Cells cultured on the mem-
brane for 96 h had dramatically reproduced and aggregated 
with each other to form cell layers. More filamentous fibers 
were formed on the surface of the cells, and cells penetrated 
into the pores of the membrane. This shows that the nHA/
PA66 membrane is favorable for BMSCs attachment and 
spreading.
AB 10 µm 100 µm
Figure 1 seM photos of nhA/PA66 membrane: micropore surface (A) and spongy surface (B).International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Observation under the inverted phase 
contrast microscope
Figure 3 shows representative phase-contrast micrographs of 
BMSCs cultured with or without the membrane, at day 4 and 
day 7. Comparing Figure 3A with Figure 3B, or Figure 3C 
with Figure 3D, cells beside the membrane exhibited the 
same morphologic characteristics – polygonal and spindle-
like shapes – as in the control group. Cellular densities in 
both groups were similar at the same indicated period, with a 
marked increase of cell population at day 7. It shows that the 
nHA/PA66 membrane has no deleterious or cytotoxic effect 
on the morphology and proliferation of BMSCs.
effect of nhA/PA66 membranes  
on viability of the BMscs
The proliferation of BMSCs cultured on the nHA/PA66 
  membrane was evaluated by MTT test (Figure 4). The cell 
number increased with the culture time on both the tested 
group and control group. The proliferation of BMSCs 
cultured on the nHA/PA66 membrane was higher than that 
of the negative control group for 1 and 4 days’ incubation 
(P , 0.05). There was no significant difference of cell number 
between the two groups for 7 and 11 days’ culture (P . 0.05) 
(Figure 4). This ascendant tendency of cell   population 
  demonstrates that nHA/PA66 membrane imposes little 
Figure 3 The cellular morphology and proliferation of BMscs cultured with nhA/PA66 membrane and BMscs (control) under inverted phase contrast microscope 
(magnification:200×) at day 4 (A, B) and day 7 (C, D). M stands for nhA/PA66 membrane.
AB
C
M
M
D
AB 50 µm 50 µm
Figure 2 seM micrographs of the BMscs cultured on the nhA/PA66 membranes for 24 h (A) and 96 h (B), respectively.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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  influence on BMSCs proliferation. PA66 is a polar compound 
  containing –COOH, –NH2 and –NH–C(O)– groups, which 
can promote adsorption of proteins such as fibronectin from 
the medium to enhance the cells’ attachment.25 The addition 
of nHA in the polymer matrix can also increase adsorption 
of proteins26 to facilitate cell attachment, spreading, and 
  proliferation. The good hydrophilicity may be another reason 
for the excellent cell affinity of nHA/PA66 membrane.20
Analysis of cell cycle
The distribution of different phases of BMSCs cultured with 
or without nHA/PA66 membrane is reported in Table 1. 
The cell cycle of BMSCs cultured with nHA/PA66 was not 
affected in comparison with the control group. Although 
most cells were blocked in the G0G1 phase due to contact 
inhibitation resulting from high cell density for 4 and 7 days’ 
incubation in both groups, cells in the S and G2M phases 
of the test group were higher than in the control group. The 
results suggest that the proliferation of BMSCs cultured on 
nHA/PA66 porous membrane is promoted. The results of in 
vitro experiments indicate that nHA/PA66 membrane has 
good cell affinity and excellent biocompatibility.
Biocompatibility in vivo
A subcutaneous implantation test is an important step to 
explore host response to foreign materials. Three time points 
were selected to investigate the tissue reaction at acute 
(one week), transitional (four weeks), and chronic phases 
(eight weeks) respectively. The wounds and implantation sites 
were free from suppuration and necrosis after subcutaneous 
implantation in all periods. Histological study revealed a 
fibrous capsid with inflammatory cellular infiltration around 
the membrane at 1 week (Figure 5A). It indicated that the 
implant induced a mild acute inflammation, which was char-
acterized by the infiltration of inflammatory cells – mainly 
polymorphonuclear cells and lymphocytes – at the interface 
between the implant and tissue (Figure 5B). Observation at 
4 weeks showed a reduced inflammatory infiltrate. Sparse 
neovascularization could be observed within the porous 
structure of the membrane. The capsule became better orga-
nized. At 8 weeks, the fibrous encapsulation was well-defined, 
thinner and more mature with pronounced vascularization 
around the membrane (Figure 5C). No severe inflammation, 
hemorrhage or necrosis was induced around the implants. 
Over the time, the surrounding connective tissues displayed 
a reduced inflammation process and the membrane was 
present at all evaluation points with no signs of resorption. 
Foreign body reaction, which is indicated by multinucleated 
giant cells, was not observed throughout the study period. 
Absence of a foreign body reaction negates the necessity of 
additional surgery for removal of the device.27
In our previous study, nano-hydroxyapatite/polyamide 
(nHA/PA) composite scaffolds were implanted in rabbit 
  mandibles. At 8 weeks post-implantation, the boundary 
between material and host bone became unclear due to 
the sufficient formation of mature bone tissues which had 
ingrown into the pores of the artificial scaffold and bonded 
tightly with the material. With the implantation period pro-
longed, new bone regenerated and penetrated through the 
interconnective pores to the center of the scaffolds, increasing 
the quantity and density of the defective area. At 12 weeks, 
the interface between material and host bone was hardly 
detectable and formed a close union without any gap.17 The 
previous study confirmed the extensive osteoconductivity 
and bone regeneration potential of the nano-hydroxyapatite/
polyamide (nHA/PA) composite scaffolds.
As a novel membrane designed for GBR, the effect 
of nHA/PA66 membrane will be further investigated 
in our subsequent GBR experimental study. Within the 
limitation of the present study, the results indicate that 
the nHA/PA66 composite has desirable in vivo biocom-
patibility. Since the body didn’t exclude the membrane 
and the composite incorporated with surrounding tissue 
harmoniously, it is possible to maintain the membrane in 
situ without retrieval.
Table 1 Distribution in the different phases of BMscs (control) 
and BMscs cultured with nhA/PA66 membrane
Sample G0G1 S G2M
1 d 4 d 7 d 1 d 4 d 7 d 1 d 4 d 7 d
nhA/PA66 11.8 74.8 72.7 67.1 14.4 15.3 21.1 10.7 12.0
control 12.4 77.9 81.8 50.2 13.6 11.4 37.4 8.5 6.8
Abbreviations:  BMscs,  bone  marrow  stromal  cells;  nhA/PA66,  nano-
hydroxyapatite/polyamide 66.
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Figure 4 The proliferation of BMscs (control) and BMscs cultured with nhA/PA66 
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Conclusions
The interest in developing an ideal barrier membrane for 
GTR or GBR drives us to focus on preparing the novel 
nano-hydroxyapatite/polyamide 66 membrane. The results 
demonstrate that the n-HA/PA66 membrane is a gradient 
porous 3-D structure with a microporous dense layer on 
one side and a macroporous spongy layer on the other side. 
In vitro experiments show that nHA/PA66 membrane has 
good affinity for BMSCs attachment, and no negative effects 
on cell viability and proliferation. Subsequently, a subcuta-
neous implantation test was employed for in vivo evaluation 
of the bio-compatibility of the membrane. Macroscopic and 
histological observation revealed no foreign body reaction 
and a reduced inflammation process. The good biocompat-
ibility of the membrane can meet the requirement of GBR. 
The nHA/PA66 membrane has the potential to be employed 
as a novel barrier membrane.
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